Dr Ira Martin Garonzik, MD | |
5051 Greenspring Ave, Suite 101, Baltimore, MD 21209-4354 | |
(410) 664-3680 | |
(410) 664-3686 |
Full Name | Dr Ira Martin Garonzik |
---|---|
Gender | Male |
Speciality | Neurosurgery |
Experience | 27 Years |
Location | 5051 Greenspring Ave, Baltimore, Maryland |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104894781 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | D0057725 (Maryland) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Sinai Hospital Of Baltimore | Baltimore, MD | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ira M. Garonzik, M.d., P.a. | 7113955295 | 2 |
News Archive
RNAssist (Cambridge UK) and Rapid Labs Ltd (Colchester, UK) have launched the virusPHIX™ range of virus inactivating and RNA stabilising transport media, following successful SARS-CoV-2 inactivation testing carried out by Public Health England (PHE).
About one-fourth of people with diabetes develop painful foot ulcers, which are slow to heal due to low oxygen in the wound from impaired blood vessels and increased inflammation. These wounds can become chronic, leading to poor quality of life and potential amputation.
We all know that smoking and drinking when pregnant can harm the baby, but new research published in The Journal of Physiology suggests that poor diet may also cause long-lasting, irreversible damage in offspring from heart disease to diabetes.
Idera Pharmaceuticals, Inc. today announced positive interim results from a Phase 1 clinical trial of IMO-2125 in patients with chronic hepatitis C virus infection (HCV). IMO-2125 is an agonist of Toll-like Receptor 9 that Idera designed to treat HCV by inducing endogenous interferon-alpha and other Th1-type cytokines and chemokines.
› Verified 9 days ago
Entity Name | Ira M. Garonzik, M.d., P.a. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1619097359 PECOS PAC ID: 7113955295 Enrollment ID: O20050729000904 |
News Archive
RNAssist (Cambridge UK) and Rapid Labs Ltd (Colchester, UK) have launched the virusPHIX™ range of virus inactivating and RNA stabilising transport media, following successful SARS-CoV-2 inactivation testing carried out by Public Health England (PHE).
About one-fourth of people with diabetes develop painful foot ulcers, which are slow to heal due to low oxygen in the wound from impaired blood vessels and increased inflammation. These wounds can become chronic, leading to poor quality of life and potential amputation.
We all know that smoking and drinking when pregnant can harm the baby, but new research published in The Journal of Physiology suggests that poor diet may also cause long-lasting, irreversible damage in offspring from heart disease to diabetes.
Idera Pharmaceuticals, Inc. today announced positive interim results from a Phase 1 clinical trial of IMO-2125 in patients with chronic hepatitis C virus infection (HCV). IMO-2125 is an agonist of Toll-like Receptor 9 that Idera designed to treat HCV by inducing endogenous interferon-alpha and other Th1-type cytokines and chemokines.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Ira Martin Garonzik, MD 5051 Greenspring Ave, Suite 101, Baltimore, MD 21209-4354 Ph: (410) 664-3680 | Dr Ira Martin Garonzik, MD 5051 Greenspring Ave, Suite 101, Baltimore, MD 21209-4354 Ph: (410) 664-3680 |
News Archive
RNAssist (Cambridge UK) and Rapid Labs Ltd (Colchester, UK) have launched the virusPHIX™ range of virus inactivating and RNA stabilising transport media, following successful SARS-CoV-2 inactivation testing carried out by Public Health England (PHE).
About one-fourth of people with diabetes develop painful foot ulcers, which are slow to heal due to low oxygen in the wound from impaired blood vessels and increased inflammation. These wounds can become chronic, leading to poor quality of life and potential amputation.
We all know that smoking and drinking when pregnant can harm the baby, but new research published in The Journal of Physiology suggests that poor diet may also cause long-lasting, irreversible damage in offspring from heart disease to diabetes.
Idera Pharmaceuticals, Inc. today announced positive interim results from a Phase 1 clinical trial of IMO-2125 in patients with chronic hepatitis C virus infection (HCV). IMO-2125 is an agonist of Toll-like Receptor 9 that Idera designed to treat HCV by inducing endogenous interferon-alpha and other Th1-type cytokines and chemokines.
› Verified 9 days ago
Dr. Whitney Erin Parker, MD, PHD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 600 N Wolfe Street, Phipps 554, Baltimore, MD 21287 Phone: 410-955-7851 Fax: 410-367-3255 | |
Kimberly Ashayeri, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 600 N Wolfe Street, Meyer 7-113, Baltimore, MD 21287 Phone: 443-287-4934 Fax: 410-502-3399 | |
Dr. Richard Louis Cohen, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1 Cornelius Ct, Baltimore, MD 21208 Phone: 410-764-3100 | |
Dr. William Wallace Ashley Jr., M.D., PH.D., M.B.A. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5051 Greenspring Ave, Suite 300, Baltimore, MD 21209 Phone: 410-601-4417 Fax: 410-601-7138 | |
Dr. James Edmond Conway, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5051 Greenspring Ave, Suite 101, Baltimore, MD 21209 Phone: 410-664-3680 Fax: 410-664-3686 | |
Dr. Daniel Michael Sciubba, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 600 N Wolfe St, Meyer Building 8-161, Baltimore, MD 21287 Phone: 410-491-8330 Fax: 410-502-5768 | |
Hatem S Abdo, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 19 Fontana Ln, Ste 206, Baltimore, MD 21237 Phone: 410-391-6904 Fax: 410-686-6640 |